{
    "eid": "2-s2.0-85021899740",
    "title": "The incidence rates and survival of gallbladder cancer in the USA",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "gallbladder cancer",
        "incidence",
        "race",
        "socioeconomic factor",
        "survival"
    ],
    "authors": [
        "Veeravich Jaruvongvanich",
        "Ju Dong Yang",
        "Thoetchai Peeraphatdit",
        "Lewis R. Roberts"
    ],
    "citedby-count": 27,
    "ref-count": 38,
    "ref-list": [
        "Marital status and survival in patients with cancer",
        "Papillary carcinomas of the gallbladder: Analysis of noninvasive and invasive types",
        "SWOG S0809: A phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma",
        "Impact of sex, age, and ethnicity/race on the survival of patients with rectal cancer in the United States from 1988 to 2012",
        "Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy",
        "Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site",
        "Is there a link between oestrogen therapy and gallbladder disease?",
        "Cholecystectomy and changing mortality from gallbladder cancer",
        "Gallbladder cancer: Can newer insights improve the outcome?",
        "S0941: A phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma",
        "Prevalence and ethnic differences in gallbladder disease in the United States",
        "Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002",
        "Improved estimates of cancer-specific survival rates from populationbased data",
        "Permutation tests for joinpoint regression with applications to cancer rates",
        "Incidence pattern and survival for gallbladder cancer over three decades - An analysis of 10301 patients",
        "The recent decline in gallbladder cancer mortality in Europe",
        "National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: A population-based analysis",
        "Survival outcomes in advanced laryngeal cancer",
        "A review of recent data in the treatment of gallbladder cancer: What we know, what we do, and what should be done",
        "Sex disparities in cancer mortality: The risks of being a man in the United States",
        "Racial disparities in cholecystectomy rates during hospitalizations for acute gallstone pancreatitis: A national survey",
        "Gender and gallstone disease",
        "Gallbladder cancer worldwide: Geographical distribution and risk factors",
        "Squamous cell and adenosquamous carcinomas of the gallbladder: Clinicopathological analysis of 34 cases identified in 606 carcinomas",
        "The effect of different dosing regimens of motesanib on the gallbladder: A randomized phase 1b study in patients with advanced solid tumors",
        "Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: Eliciting early response signals from phase 1 trials",
        "Changing demographics in laparoscopic cholecystectomy performed in the United States: Hospitalizations from 1998 to 2010",
        "Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer",
        "Sex, race, and age disparities in the improvement of survival for gastrointestinal cancer over time",
        "Association between race/ethnicity and survival of melanoma patients in the United States over 3 decades: A secondary analysis of SEER data",
        "Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998",
        "Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States",
        "Disparities by race, age, and sex in the improvement of survival for major cancers: Results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010",
        "Current management of gallbladder carcinoma"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rochester",
            "@id": "60026829",
            "affilname": "Mayo Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026829",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Honolulu",
            "@id": "60013791",
            "affilname": "University of Hawai\u02bbi at M\u0101noa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013791",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}